TOPLINE: Surgical delay beyond 42 days after breast cancer diagnosis led to exponential growth in mortality risk for patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) breast cancer. Time to surgery from diagnostic biopsy showed varying impacts across breast cancer subtypes, with patients with HR+/HER2− breast cancer facing the highest risk. METHODOLOGY: Previous […]
The post Surgical Delay Risk Varies by Breast Cancer Subtype first appeared on News Health.
Author : News Health
Publish date : 2025-03-26 13:30:00
Copyright for syndicated content belongs to the linked Source.